FDA Clearance Tracker · P200035-S035
OrganOx metra® System
Last checked: Nov 20, 2026Latest source record: Mar 30, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 30, 2026
Approved
Time to decision
89 days
Received Dec 31, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P200035-S035
- Device name
- OrganOx metra® System
- Applicant
- Organox Limited
- Applicant location
- Oxford
- Received
- Dec 31, 2025
- Decided
- Mar 30, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P200035
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for updated labeling (instructions for use, patient brochure, quick reference guide, training videos, and marketing materials (corporate brochure, surgeon brochure, and corporate overview)
Source documents
Other decisions for Organox Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200035 · Decided Dec 9, 2021 · 512 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.